MET and osteosarcoma: Initially identified as a product of chromosomal rearrangement induced by carcinogens in the human osteosarcoma cell line HOS, MET was formed through fusion between the translocated promoter region (TPR) locus on chromosome one and the MET sequence on chromosome 7.